CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

cord blood hematopoietic stem cell

Cell therapyexperimental

Clinical trial activity

21 trials · 33 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
14
Phase 3
4
Phase 4
0

Earliest trial started Dec 1, 2008 (NCT00864227)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • leukocytesTissue restoration

    leukocytes tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cord blood hematopoietic stem cell
  • cord blood mononuclear cells
  • hematopoietic umbilical cord blood
  • human cord blood mononuclear cell
  • human cord blood mononuclear cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06848582N/ANov 1, 2024Sun Yat-Sen University
NCT06631391Phase 1Nov 1, 2024Sun Yat-Sen University
NCT05999656N/AMay 28, 2023Nanjing Medical University, Qilu Pharmaceutical Co., Ltd.
NCT05628272N/AOct 1, 2022Chinese Medical Association, Shandong Province Qianfoshan Hospital
NCT05071638Phase 3Oct 1, 2021Guangdong Women and Children Hospital
NCT05087498Phase 3Sep 1, 2021Guangdong Women and Children Hospital
NCT04689425Phase 3Mar 30, 2021Peking University
NCT05000593N/AJul 1, 2020Shandong Province Qianfoshan Hospital
NCT04440670Phase 3Jun 20, 2020Foshan Chancheng Central Hospital, Foshan Women and Children Hospital, Guangdong Cord Blood Bank, Guangdong Women and Children Hospital, Guangzhou Medical University, Heyuan Women and Children Hospital, Southern Medical University, Sun Yat-Sen University
NCT04098029Phase 2Sep 1, 2019InBio, LLC, Medical Centre Dinasty
NCT05560672N/ASep 1, 2019Shandong Province Qianfoshan Hospital
NCT04099381Phase 1/Phase 2 (Phase 2)Aug 10, 2019InBio, LLC, Medical Centre Dinasty
NCT03979742Phase 2Jul 1, 2019Amarex Clinical Research, StemCyte, Inc.
NCT03399773Phase 2May 15, 2018National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Nohla Therapeutics, Inc., University of Washington
NCT03431480Phase 1Feb 16, 2018Murdoch University, University of Melbourne
NCT02952716Phase 1/Phase 2 (Phase 2)Oct 1, 2016Liaocheng People's Hospital
NCT01742533Phase 1/Phase 2 (Phase 2)Mar 1, 2012Beike Biotech
NCT01443689Phase 1/Phase 2 (Phase 2)Jul 1, 2011Beike Biotech, Kunming Medical University
NCT01332006Phase 2Nov 1, 2009University of Brescia, USD TMO Adulti Piazzale Spedali Civili
NCT01343511Phase 1/Phase 2 (Phase 2)Mar 1, 2009Beike Biotech, Jiao Tong University, Jinan University
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (33)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beike BiotechFor profit3312009
Guangdong Women and Children HospitalAcademic/Hospital3312020
Shandong Province Qianfoshan HospitalAcademic/Hospital3312019
Sun Yat-Sen UniversityAcademic/Hospital3232020
InBio, LLCFor profit2012019
Medical Centre DinastyAcademic/Hospital2212019
National Cancer Institute (NCI)Government2012008
National Heart, Lung, and Blood Institute (NHLBI)Government2012008
Amarex Clinical ResearchFor profit1012019
Blood and Marrow Transplant Clinical Trials NetworkAcademic/Hospital1012008
Chinese Medical AssociationAcademic/Hospital1012022
Foshan Chancheng Central HospitalAcademic/Hospital1012020
Foshan Women and Children HospitalAcademic/Hospital1012020
Guangdong Cord Blood BankAcademic/Hospital1012020
Guangzhou Medical UniversityAcademic/Hospital1012020
Heyuan Women and Children HospitalAcademic/Hospital1012020
Jiao Tong UniversityAcademic/Hospital1012009
Jinan UniversityAcademic/Hospital1012009
Kunming Medical UniversityAcademic/Hospital1012011
Liaocheng People's HospitalAcademic/Hospital1112016
33 organizations
Page 1 / 2